Application Note: Immuno-oncology: Cancer media toolbox
31 May 2023

In this application note, Promocell Gmbh provides an overview and demonstration of how to use its toolbox of cancer media to build high-quality cancer assay panels with patient-derived organoids (PDOs) to model immunotherapy function. Immuno-oncology is a unique combination of oncology and immunology. By activating or amplifying the body’s natural defenses, immuno-oncology aims to boost the immune system to fight cancer. Targeted antibodies or immunomodulators are well-known immunotherapies; adoptive cell therapy using CAR-T or TCR cells is particularly important, representing a significant breakthrough in cancer therapy with the recent approval of several CAR-T therapies.